Home › Oral Cancer › New York › Staten Island
Oral Cancer clinical trials in Staten Island, NY
3 studies for Oral Cancer are looking for participants at sites in and around Staten Island (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
RecruitingPhase 2/3
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi away
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
RecruitingPhase 2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi away
About Oral Cancer
Oral cancer can form in the mouth or throat but usually begins in the tongue and floor of the mouth. Read about the common oral cancer symptoms.
More about Oral Cancer on MedlinePlus
Oral Cancer trials in other cities
- Atlanta, GA9 studies
- St. Louis, MO8 studies
- Chicago, IL8 studies
- New York City, NY8 studies
- Durham, NC7 studies
- Houston, TX7 studies
- Pittsburgh, PA7 studies
- Ann Arbor, MI7 studies
- Milwaukee, WI7 studies
- Kansas City, MO7 studies
- Portland, OR7 studies
- Richmond, VA7 studies
Other studies in Staten Island
- Breast Cancer40 studies
- Non-Small Cell Lung Cancer19 studies
- Prostate Cancer16 studies
- Acute Myeloid Leukemia14 studies
- Multiple Myeloma13 studies
- Lung Cancer12 studies
- Bladder Cancer11 studies
- Cancer (all types)11 studies
- Endometrial Cancer11 studies
- Metastatic Cancer10 studies
- Ovarian Cancer9 studies
- Head and Neck Squamous Cell Carcinoma9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.